» Articles » PMID: 9741640

The Conformation of Hepatitis C Virus NS3 Proteinase with and Without NS4A: a Structural Basis for the Activation of the Enzyme by Its Cofactor

Overview
Date 1998 Sep 19
PMID 9741640
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis C virus (HCV) NS3 proteinase activity is required for the release of HCV nonstructural proteins and is thus a potential antiviral target. The enzyme requires a protein cofactor NS4A, located downstream of NS3 on the polyprotein, for activation and efficient processing.

Objectives: Comparison of the proteinase three-dimensional structure before and after NS4A binding should help to elucidate the mechanism of NS4A-dependent enzyme activation.

Study Design: We determined the crystal structure of NS3 proteinase of HCV BK isolate (genotype 1b; residues 1-189) and also the crystal structure of this proteinase complexed with HCV BK-NS4A (residues 21-34).

Results: The core region (residues 30-178) of the enzyme without cofactor (NS3P) or with bound cofactor (NS3P/4A) is folded into a trypsin-like conformation and the substrate P1 specificity pocket is essentially unchanged. However, the D1-E1 beta-loop shifts away from the cofactor binding site in NS3P/4A relative to NS3P, thereby accommodating NS4A. One result is that catalytic residues His-57 and Asp-81 move closer to Ser-139 and their sidechains adopt more 'traditional' (trypsin-like) orientation. The N-terminus (residues 1-30), while extended in NS3P, is folded into an alpha-helix and beta-strand that cover the bound cofactor of NS3P/4A. A new substrate-binding surface is formed from both the refolded N-terminus and NS4A, potentially affecting substrate residues immediately downstream of the cleavage site.

Conclusions: Direct comparison of the crystal structures of NS3P and NS3P/4A shows that the binding of NS4A improves the anchoring and orientation of the enzyme's catalytic triad. This is consistent with the enhancement of NS3P's weak residual activity upon NS4A binding. There is also significant refolding of the enzyme's N-terminus which provides new interactions with P'-side substrate residues. The binding surface for P'-side substrate residues, including the P1 specificity pocket, changes little after NS4A binding. In summary, we observe a structural basis for improved substrate turnover and affinity that follows complexation of NS3P with its NS4A cofactor.

Citing Articles

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease.

El-Araby M, Omar A, Soror S, Arold S, Khayat M, Asfour H J Adv Res. 2020; 24:251-259.

PMID: 32373358 PMC: 7195562. DOI: 10.1016/j.jare.2020.01.003.


The Discovery and Development of Boceprevir: A Novel, First-generation Inhibitor of the Hepatitis C Virus NS3/4A Serine Protease.

Howe A, Venkatraman S J Clin Transl Hepatol. 2015; 1(1):22-32.

PMID: 26357603 PMC: 4548358. DOI: 10.14218/JCTH.2013.002XX.


Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Cregar-Hernandez L, Jiao G, Johnson A, Lehrer A, Wong T, Margosiak S Antivir Chem Chemother. 2011; 21(5):209-17.

PMID: 21566267 PMC: 3095516. DOI: 10.3851/IMP1767.


Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.

Ueno T, Misawa S, Ohba Y, Matsumoto M, Mizunuma M, Kasai N J Virol. 2000; 74(14):6300-8.

PMID: 10864639 PMC: 112135. DOI: 10.1128/jvi.74.14.6300-6308.2000.


Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3.

Butkiewicz N, Yao N, Zhong W, Ingravallo P, Zhang R, Durkin J J Virol. 2001; 74(9):4291-301.

PMID: 10756044 PMC: 111946. DOI: 10.1128/jvi.74.9.4291-4301.2000.